ArticleInternational journal of hematology2026
Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan.
Fumiaki Fujii et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.